Cargando…
Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB(1) receptor availability
BACKGROUND: Obesity is a pressing public health concern worldwide. Novel pharmacological means are urgently needed to combat the increase of obesity and accompanying type 2 diabetes (T2D). Although fully established obesity is associated with neuromolecular alterations and insulin resistance in the...
Autores principales: | Kantonen, Tatu, Pekkarinen, Laura, Karjalainen, Tomi, Bucci, Marco, Kalliokoski, Kari, Haaparanta-Solin, Merja, Aarnio, Richard, Dickens, Alex M., von Eyken, Annie, Laitinen, Kirsi, Houttu, Noora, Kirjavainen, Anna K., Helin, Semi, Hirvonen, Jussi, Rönnemaa, Tapani, Nuutila, Pirjo, Nummenmaa, Lauri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794779/ https://www.ncbi.nlm.nih.gov/pubmed/34728775 http://dx.doi.org/10.1038/s41366-021-00996-y |
Ejemplares similares
-
Obesity risk is associated with brain glucose uptake and insulin resistance
por: Pekkarinen, Laura, et al.
Publicado: (2022) -
Cerebral μ-opioid and CB(1) receptor systems have distinct roles in human feeding behavior
por: Kantonen, Tatu, et al.
Publicado: (2021) -
Association of CNR1 gene and cannabinoid 1 receptor protein in the human brain
por: Pak, Kyoungjune, et al.
Publicado: (2022) -
Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety
por: Nummenmaa, Lauri, et al.
Publicado: (2020) -
Ruthenium-Mediated (18)F-Fluorination
and Preclinical Evaluation of a New CB(1) Receptor Imaging
Agent [(18)F]FPATPP
por: Lahdenpohja, Salla, et al.
Publicado: (2020)